Recent Updates
Recently added Catalysts
HUMA Positive Sentiment

Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”

Key Takeaway: Dr. Jeromy Brink, a vascular surgeon trained at Mayo Clinic, has successfully performed the first commercial implantation of Symvess in Arizona. This bioengineered blood vessel is the first and only FDA-approved option available off-the-shelf, which significantly reduces the time surgeons spend on harvesting vessels. The innovation is seen as a major advancement in the field of vascular surgery.

Market Sentiment Analysis

POSITIVE FACTORS

  • First commercial implantation of Symvess in Arizona.
  • Symvess is FDA-approved, indicating safety and efficacy.
  • Described as a revolutionary advancement in vascular surgery.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+21%
120-day peak, hindsight
Typical move
7.2%
average across 3 past catalysts
Cash runway
~9 mo
Medium dilution risk
Lead asset
Acellular Tissue Engineered Vessel
Phase 3 · Vascular Trauma

Full Press Release Details

– Jeromy Brink, MD, Mayo Clinic–trained vascular surgeon in Phoenix, is the first surgeon in Arizona to implant Symvess, the first and only FDA-approved bioengineered human blood vessel – – Symvess is available off-the-shelf in the operating room, sparing surgeons the time required to harvest a

Frequently Asked Questions

What is Symvess?

Symvess is the first and only FDA-approved bioengineered human blood vessel.

Who performed the first Symvess implantation?

Dr. Jeromy Brink, a Mayo Clinic-trained vascular surgeon, performed the first implantation.

Why is Symvess considered revolutionary?

Symvess is available off-the-shelf, saving time for surgeons compared to traditional methods.

Where was the first Symvess implantation done?

The first Symvess implantation was performed in Phoenix, Arizona.

Last updated: Aug 18, 2026